State Street’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.7M Buy
590,114
+81,096
+16% +$3.14M ﹤0.01% 2244
2026
Q1
$19.2M Buy
509,018
+48,409
+11% +$1.58M ﹤0.01% 2259
2025
Q4
$13.9M Buy
460,609
+51,864
+13% +$1.47M ﹤0.01% 2461
2025
Q3
$10.7M Buy
408,745
+148,505
+57% +$3.54M ﹤0.01% 2598
2025
Q2
$5.55M Buy
260,240
+121,438
+87% +$2.74M ﹤0.01% 2896
2025
Q1
$2.95M Buy
138,802
+24,675
+22% +$506K ﹤0.01% 3088
2024
Q4
$2.31M Buy
+114,127
New +$2.36M ﹤0.01% 3272

Other funds holding GRDN

State Street's GRDN Position: Q2 2026 in Review

State Street increased its Guardian Pharmacy Services (GRDN) stake by 16% in Q2 2026, buying an estimated $3.14M and bringing the position to 590,114 shares worth $24.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2244.

State Street first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • State Street held 590,114 shares of Guardian Pharmacy Services worth $24.7M as of Q2 2026.
  • State Street bought 81,096 Guardian Pharmacy Services shares in Q2 2026, an estimated $3.14M.
  • Guardian Pharmacy Services made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2244 holding.
  • State Street first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.